Gross Profit (TTM) Chart

View Gross Profit (TTM) for ELAN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (TTM) Chart
Start Trial

Historical Gross Profit (TTM) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 2.223B
March 31, 2026 2.141B
December 31, 2025 2.05B
September 30, 2025 1.989B
June 30, 2025 1.927B
March 31, 2025 1.908B
December 31, 2024 1.909B
September 30, 2024 1.901B
June 30, 2024 1.937B
March 31, 2024 1.866B
December 31, 2023 1.938B
September 30, 2023 1.967B
June 30, 2023 1.952B
March 31, 2023 2.023B
December 31, 2022 1.974B
September 30, 2022 2.026B
June 30, 2022 2.088B
Date Value
March 31, 2022 2.129B
December 31, 2021 2.075B
September 30, 2021 1.993B
June 30, 2021 1.857B
March 31, 2021 1.499B
December 31, 2020 1.247B
September 30, 2020 1.192B
June 30, 2020 1.200B
March 31, 2020 1.335B
December 31, 2019 1.400B
September 30, 2019 1.412B
June 30, 2019 1.394B
March 31, 2019 1.307B
December 31, 2018 1.296B
September 30, 2018 958.90M
June 30, 2018 616.30M
March 31, 2018 327.00M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Eli Lilly & Co. 66.44B
Zoetis, Inc. 6.683B
ANI Pharmaceuticals, Inc. 505.18M
EyePoint, Inc. -0.51M
Amylyx Pharmaceuticals, Inc. -0.369M